Rise and persistence of global M1T1 clone of Streptococcus pyogenes

Emerging Infectious Diseases

Volumn 14, Issue 10, 2008, Pages 1511-1517

  Aziz, Ramy K ^a,b,e   Kotb, Malak ^c,d  

^a CAIRO UNIVERSITY   (Egypt)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEASE; SDA1 PROTEIN; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; BACTERIAL SURVIVAL; BLOOD CLOTTING DISORDER; CLONE; DERMIS; EDEMA; FASCIA; HOST; HYPOTENSION; INFECTION; KIDNEY DISEASE; LIVER DISEASE; MICROBIAL COMMUNITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PREVALENCE; RASH; REVIEW; SCARLET FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SUBCUTANEOUS FAT; TISSUE NECROSIS; TOXIC SHOCK SYNDROME; VIRULENCE;

EPIDEMIOLOGY, MOLECULAR; GENES, BACTERIAL; HUMANS; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PHAGES; STREPTOCOCCUS PYOGENES; VIRULENCE;

EID: 54249155508     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1410.071660     Document Type: Review

References (40)

1. Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstratiou A, Thompson TA, et al. Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis. 2002;34:28-38. DOI: 10.1086/324621
2. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med. 2002;8:1398-404. DOI: 10.1038/nm800
3. Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, et al. Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun. 2000;68:3523-34. DOI: 10.1128/IAI.68.6.3523-3534.2000
4. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med. 1996;335:547-54. DOI: 10.1056/NEJM199608223350803
5. Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis. 1992;14:298-307.
6. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993;269:384-9. DOI: 10.1001/jama.269.3.384
7. Low DE, Schwartz B, McGeer A. The reemergence of severe group A streptococcal disease: an evolutionary perspective. In: Scheld WM, Armstrong D, Hughes JM, editors. Emerging infections. Washington: ASM Press; 1997. p. 93-123.
8. Infections WGoSS. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA. 1993;269:390-1. DOI: 10.1001/jama.269.3.390
9. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18-24. DOI: 10.1016/S0002-9343(97)00160-5
10. Sharkawy A, Low DE, Saginur R, Gregson D, Schwartz B, Jessamine P, et al. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis. 2002;34:454-60. DOI: 10.1086/338466
11. Johnson DR, Wotton JT, Shet A, Kaplan EL. A comparison of group A streptococci from invasive and uncomplicated infections: Are virulent clones responsible for serious streptococcal infections? J Infect Dis. 2002;185:1586-95. DOI: 10.1086/340576
12. Rogers S, Commons R, Danchin MH, Selvaraj G, Kelpie L, Curtis N, et al. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A Streptococcus infections. J Infect Dis. 2007;195:1625-33. DOI: 10.1086/513875
13. Ikebe T, Murai N, Endo M, Okuno R, Murayama S, Saitoh K, et al. Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan. Epidemiol Infect. 2003;130:569-72.
14. Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet. 1992;339:518-21. DOI: 10.1016/0140-6736(92)90339-5
15. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A. 2001;98:4658-63. DOI: 10.1073/pnas.071559398
16. Beres SB, Musser JM. Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS One. 2007;2:e800. DOI: 10.1371/journal.pone.0000800
17. Beres SB, Sylva GL, Sturdevant DE, Granville CN, Liu M, Ricklefs SM, et al. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A. 2004;101:11833-8. DOI: 10.1073/pnas.0404163101
18. Cleary PP, LaPenta D, Vessela R, Lam H, Cue D. A globally disseminated M1 subclone of group A streptococci differs from other subclones by 70 kilobases of prophage DNA and capacity for high-frequency intracellular invasion. Infect Immun. 1998;66:5592-7.
19. Aziz RK, Edwards RA, Taylor WW, Low DE, McGeer A, Kotb M. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol. 2005;187:3311-8. DOI: 10.1128/JB.187.10.3311-3318. 2005
20. Aziz RK, Ismail SA, Park HW, Kotb M. Post-proteomic identification of a novel phage-encoded streptodornase, Sda1, in invasive M1T1 Streptococcus pyogenes. Mol Microbiol. 2004;54:184-97. DOI: 10.1111/j.1365-2958.2004. 04255.x
21. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis. 2005;192:771-82. DOI: 10.1086/432514
22. Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang HY, Cohoon M, et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 2005;33:5691-702. DOI: 10.1093/nar/gki866
23. Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med. 1987;317:146-9.
24. Schlievert PM, Bettin KM, Watson DW. Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis. 1979;140:676-81.
25. Nelson K, Schlievert PM, Selander RK, Musser JM. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med. 1991;174:1271-4. DOI: 10.1084/jem.174.5.1271
26. Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, Kotb M, et al. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol. 2006;16:396-400. DOI: 10.1016/j.cub.2005.12.039
27. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, et al. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med. 2007;13:981-5. DOI: 10.1038/nm1612
28. Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low DE, El-Ahmedy O, et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun. 1999;67:1871-7.
29. Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, et al. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol. 1996;156:3057-64.
30. Tillet WS, Sherry S, Christensen LR. Streptococcal desoxyribonuclease: significance in lysis of purulent exudates and production by srains of hemolytic streptococci. Proc Soc Exp Biol Med. 1948;68:184-8.
31. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, Long RD, et al. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci U S A. 2005;102:1679-84. DOI: 10.1073/pnas.0406641102
32. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532-5. DOI: 10.1126/science.1092385
33. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2006;2:e5. DOI: 10.1371/journal.ppat.0020005
34. Savic DJ, McShan WM, Ferretti JJ. Autonomous expression of the slo gene of the bicistronic nga-slo operon of Streptococcus pyogenes. Infect Immun. 2002;70:2730-3. DOI: 10.1128/IAI.70.5.2730-2733.2002
35. Ghosh J, Caparon MG. Specificity of Streptococcus pyogenes NAD(+) glycohydrolase in cytolysin-mediated translocation. Mol Microbiol. 2006;62:1203-14. DOI: 10.1111/j.1365-2958.2006.05430.x
36. Talkington DF, Schwartz B, Black C, Todd J, Elliott J, Breiman R, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun. 1993;61: 3369-74.
37. Kansal RG, McGeer A, Low DE, Norrby-Teglund A, Kotb M. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun. 2000;68:6362-9. DOI: 10.1128/IAI.68.11.6362-6369. 2000
38. Cole JN, McArthur JD, McKay FC, Sanderson-Smith ML, Cork AJ, Ranson M, et al. Trigger for group A streptococcal M1T1 invasive disease. FASEB J. 2006;20:1745-7. DOI: 10.1096/fj.06-5804fje
39. Aziz RK, Pabst MJ, Jeng A, Kansal R, Low DE, Nizet V, et al. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol. 2004;51:123-34. DOI: 10.1046/j.1365-2958.2003.03797.x
40. Lyon WR, Gibson CM, Caparon MG. A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J. 1998;17:6263-75. DOI: 10.1093/emboj/17.21.6263